These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7682429)

  • 1. Platelet serotonin is a mediator potentially involved in anaphylactic reaction to neuromuscular blocking drugs.
    Bermejo N; Guéant JL; Mata E; Gérard P; Moneret-Vautrin DA; Laxenaire MC
    Br J Anaesth; 1993 Mar; 70(3):322-5. PubMed ID: 7682429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diagnosis of anaphylactic reactions to neuromuscular blocking drugs.
    Laroche D; Lefrançois C; Gérard JL; Dubois F; Vergnaud MC; Guéant JL; Bricard H
    Br J Anaesth; 1992 Dec; 69(6):611-4. PubMed ID: 1366342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anaphylaxis during anesthesia--especially from neuromuscular blocking agents].
    Kageyama K; Hayakawa Y; Nakajima Y; Hashimoto S
    Masui; 2011 Jan; 60(1):55-66. PubMed ID: 21348251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anaphylactic reaction as a side-effect of administration of general anesthetics and neuromuscular blocking agents].
    Milavec D; Husedzinović I
    Lijec Vjesn; 2006; 128(9-10):317-21. PubMed ID: 17128671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of in vitro leukocyte histamine release in allergy to muscle relaxant drugs.
    Mata E; Guéant JL; Moneret-Vautrin DA; Bermejo N; Gérard P; Nicolas JP; Laxenaire MC
    Allergy; 1992 Oct; 47(5):471-6. PubMed ID: 1283060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to prevent an anaphylactic reaction to a second neuromuscular blocking drug during anaesthesia.
    Fisher MM; Merefield D; Baldo B
    Br J Anaesth; 1999 May; 82(5):770-3. PubMed ID: 10536561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro tests in anaphylactic reactions to anaesthetic agents.
    Assem ES
    Agents Actions; 1991 May; 33(1-2):208-11. PubMed ID: 1716831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of neuromuscular blockers and their antagonists.
    Naguib M; Magboul MM
    Middle East J Anaesthesiol; 1998 Jun; 14(5):341-73. PubMed ID: 9785339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects of neuromuscular blockers and their antagonists.
    Naguib M; Magboul MM
    Drug Saf; 1998 Feb; 18(2):99-116. PubMed ID: 9512917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylactoid reactions to neuromuscular blockers: major role of IgE antibodies and possible contribution of IgE-independent mechanisms.
    Assem ES
    Monogr Allergy; 1992; 30():24-53. PubMed ID: 1280766
    [No Abstract]   [Full Text] [Related]  

  • 11. Histamine release assay and radioimmunoassay for the detection of IgE antibodies against neuromuscular blocking drugs.
    Guilloux L; Richard-Blum S; Ville G; Motin J
    Ann Fr Anesth Reanim; 1993; 12(2):182-6. PubMed ID: 7690204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro displacement of vasoactive mediators from plasma proteins: a possible mechanism for pseudo-allergic reactions to neuromuscular blocking drugs.
    Williams WR; Shale DJ
    Br J Anaesth; 1992 Nov; 69(5):508-10. PubMed ID: 1281662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of in vitro tests for the IgE-dependent and the IgE-independent anaphylactoid reactions to muscle relaxants.
    Assem ES
    Ann Fr Anesth Reanim; 1993; 12(2):203-11. PubMed ID: 7690206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine release and atracurium.
    Watkins J
    Br J Anaesth; 1986; 58 Suppl 1():19S-22S. PubMed ID: 2423103
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic and predictive test procedures in patients with life-threatening anaphylactic and anaphylactoid drug reactions.
    Assem ES
    Allergol Immunopathol (Madr); 1984; 12(1):61-70. PubMed ID: 6203389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?
    Spoerl D; Nigolian H; Czarnetzki C; Harr T
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylactic and anaphylactoid reactions to intravenous anesthetic agents.
    Haber H
    Middle East J Anaesthesiol; 1980 Jun; 5(7):471-80. PubMed ID: 6162078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating the cellular and humoral components of neuromuscular blocking agent-induced anaphylactic reactions in patients undergoing anaesthesia.
    Aalberse RC; Kleine Budde I; Mulder M; Stapel SO; Paulij W; Leynadier F; Hollmann MW
    Br J Anaesth; 2011 May; 106(5):665-74. PubMed ID: 21414980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of IgE in anaphylactoid reactions during anaesthesia.
    Fisher MM; Baldo BA
    Ann Fr Anesth Reanim; 1985; 4(2):133-6. PubMed ID: 2408509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing muscle relaxant anaphylaxis with monovalent haptens. A preliminary study.
    Moneret-Vautrin DA; Motin J; Mata E; Guéant JL; Kanny G; Widmer S; Laxenaire MC
    Ann Fr Anesth Reanim; 1993; 12(2):190-202. PubMed ID: 7690205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.